Mekanik Mitral Kapaklı Gebede Mitral Trombüs ve Serebrovasküler Olay

Sayın L, Yüce T. Gebelikte Kalp Hastalıkları. Perinatoloji Dergisi 2013;21(3):125-31.

Elkayam U, Bitar F. Valvular heart disease and pregnancy: Part II: prosthetic valves. J Am Coll Cardiol. 2005 Mar 1;45(5):813–822.

Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II Study. J Am Coll Cardiol. 2018;71(21):2419–30.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241.

D'Souza R, Ostro J, Shah PS, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509–1516.

McLintock C. Anticoagulant therapy in pregnant women with mechanical heart valves: no easy options. Thromb Res. 2011;127 Suppl 3:S56–60.

Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160(2):191–196.

McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical heart valves treated with enoxaparin. BJOG. 2009;116(12):1585–92.

Vitale N, De Feo M, De Santo LS, et al. Dangers of discontinuing anticoagulation in pregnant women with mechanical heart valves: a lesson learned from a fatal case. J Heart Valve Dis. 2004;13(3):367–369.

Homma S, Sacco RL, Di Tullio MR, et al. Atrial anatomy and the risk of paradoxical embolism: the PFO story. J Am Coll Cardiol. 2005;46(5):747–753.

AHA/ACC Guidelines for the Management of Patients With Valvular Heart Disease. Circulation. 2014;129(23):e521–643.

Elkayam U, Goland S, Pieper PG, Silversides CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016;68(4):396–410.